WIM
SGMO

Westside Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Westside Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-600
Closed -$2 – 848
2022
Q3 		$2 Hold
600
– – ﹤0.01% 768
2022
Q2 		$2 Hold
600
– – ﹤0.01% 765
2022
Q1 		$3 Hold
600
– – ﹤0.01% 729
2021
Q4 		$4 Hold
600
– – ﹤0.01% 701
2021
Q3 		$5 Hold
600
– – ﹤0.01% 661
2021
Q2 		$7 Hold
600
– – ﹤0.01% 610
2021
Q1 		$7 Buy
+600
New +$8.09K ﹤0.01% 597

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Westside Investment Management's SGMO Position: Q4 2022 in Review

Westside Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 600 shares — an estimated $2 sold.

Westside Investment Management first reported a position in SGMO in Q1 2021 and held it in 7 quarters. The position peaked at $7 in Q2 2021. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

  • Westside Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
  • Westside Investment Management sold 600 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $2.
  • Westside Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2021 and held it in 7 quarters.
  • Westside Investment Management's SANGAMO THERAPEUTICS INC position peaked at $7 in Q2 2021.
  • 182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Westside Investment Management's 13F filing for Q4 2022, filed 31 Jan 2023.